Skip to main content

Table 6 Summary of the statistics done per ERH for the L group. (Used to plot Figs. 4 and 3)

From: The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization

ERH

Sample Size

Avg. M II ± SD

Avg. MR ± SD

Avg. FE ± SD

Avg. FR ± SD

Avg. Embryo ± SD

Avg. CR ± SD

Avg. HQ Embryo ± SD

Avg. HQER ± SD

Outcome

35

316

7.3 ± 5.0

.62 ± .19

4.7 ± 3.7

.52 ± .26

3.2 ± 1.9

.79 ± .31

1.9 ± 1.4

.56 ± .3

.39

36

1391

7.7 ± 5.0

.60 ± .19

5.3 ± 3.8

.54 ± .23

3.7 ± 1.9

.78 ± .29

2.0 ± 1.4

.54 ± .28

.40

37

1007

8.5 ± 5.5

.61 ± .18

5.8 ± 4.1

.55 ± .24

4.1 ± 1.9

.74 ± .31

2.0 ± 1.5

.51 ± .29

.42

38

124

8.9 ± 5.1

.61 ± .17

6.2 ± 4.1

.55 ± .25

4.3 ± 1.9

.69 ± .34

2.2 ± 1.7

.52 ± .31

.40

  1. Note. Distribution of the groups of ERHs in L Group. The mean of oocytes in metaphase 2, maturation rate, fertilized eggs, fertilization rate. SD Standard Deviation. Outcome = Clinical Pregnancy Occurrence Positive Percentage